Sort
17,288 grants matching “multiple sclerosis”
Commensal microbes and sexual dimorphism in autoimmunity
$191,932Alexander V Chervonsky · University Of Chicago · R21 · FY2014 · AI
Racial Disparities in Multiple Sclerosis: Quality of Care and Patient Experiences
$191,927Jagriti Jackie Bhattarai · Johns Hopkins University · K23 · FY2021 · MD
Sphingosine-1-phosphate signaling in pertussis pathogenesis and therapeutics
$191,875Nicholas H. Carbonetti · University Of Maryland Baltimore · R21 · FY2016 · AI
Use of use of dimethyl fumarate for targeting autoimmunity in type 1 diabetes
$191,875Francesco Vendrame · University Of Miami School Of Medicine · R21 · FY2022 · AI
Does microglial TNFR2 contribute to the protective role of membrane TNF in EAE?
$191,875Roberta Brambilla · University Of Miami School Of Medicine · R21 · FY2015 · NS
Elucidation of specific nucleocytoplasmic trafficking pathways that are disrupted in C9ORF72 ALS
$191,875Zane Zeier · University Of Miami School Of Medicine · R21 · FY2018 · NS
Extracellular matrix regulation of myelination
$191,849Holly A Colognato · State University New York Stony Brook · R01 · FY2006 · NS
Modulating Glial Fate and Function in Development and Disease
$191,818Paul Joseph Tesar · Case Western Reserve University · R35 · FY2025 · NS
SYNTHETIC ANALOGUES OF ZINC ENZYMES
$191,762Columbia Univ New York Morningside · R01 · FY2001 · GM
Autoreactive B Cell Development in Autoimmune Disease
$191,695Eric Meffre · Yale University · U19 · FY2012 · AI
ABNORMALITIES IN CNS MYELINATED FIBERS
$191,550New York University School Of Medicine · R01 · FY2000 · NS
Longitudinal Measurement of Neurodegeneration in two Murine Models of Multiple Sclerosis: A Clinical and Histopathologic Validation Study
$191,540Francesca Gilli · Dartmouth-Hitchcock Clinic · R21 · FY2022 · NS
RNA Processing Machines in Biology and Disease
$191,535Danesh Moazed · Harvard Medical School · R35 · FY2023 · GM
Function and Targeting of CCR6/CCL20 in Autoimmune Psoriasiform Skin Disease
$191,449Sam T Hwang · University Of California At Davis · R01 · FY2015 · AR
Imaging the Sphingosine-1-Phosphate Receptor 1 (S1P1)
$191,414Zhude Tu · Washington University · P41 · FY2021 · EB
SAFETY & EFFICACY OF ATORVASTATIN IN NEWLY DIAGNOSED TYPE 1 DIABETES
$191,404Steven M Willi · Children'S Hosp Of Philadelphia · R01 · FY2009 · FD
Studying the role of the nuclear lamina in age dependent demyelination
$191,388Quasar S Padiath · University Of Pittsburgh At Pittsburgh · R21 · FY2014 · AG
Refinement of GM1416-a Drug to Treat Neurodegeneration
$191,368Gliamed, Inc. · R43 · FY2003 · NS
Demyelinating Disease-Viral and Cellular Function
$191,257Xuming Zhang · Univ Of Arkansas For Med Scis · R01 · FY2006 · NS
Impact of human anti-NMDA receptor antibodies on glutamate receptor signaling, calcium mobilization, and hippocampal neuronal circuits in autoimmune encephalitis
$191,251David Roger Benavides · University Of Maryland Baltimore · K08 · FY2020 · NS
Impact of human anti-NMDA receptor antibodies on glutamate receptor signaling, calcium mobilization, and hippocampal neuronal circuits in autoimmune encephalitis
$191,251David Roger Benavides · University Of Maryland Baltimore · K08 · FY2019 · NS
Inappropriate Intrusion of Syntaphilin into Dendrites Kills Neurons in Pathology
$191,250Shing Yan Chiu · University Of Wisconsin-Madison · R21 · FY2017 · NS
TNF signaling methods initiating in vitro sleep-like states
$191,250James Martin Krueger · Washington State University · R21 · FY2017 · NS
Impact of human anti-NMDA receptor antibodies on glutamate receptor signaling, calcium mobilization, and hippocampal neuronal circuits in autoimmune encephalitis
$191,250David Roger Benavides · University Of Maryland Baltimore · K08 · FY2022 · NS
Antiviral Therapy for Polyomavirus Infection
$191,250Aron Lukacher · Emory University · R21 · FY2007 · AI